Goldline Pharmaceutical SME IPO GMP 2026
Last Updated : 18-Jun-2026 15:12 IST
Goldline Pharmaceutical has announced a ₹12 Cr. SME IPO in the Pharmaceuticals sector. This book build issue comes with a price band of ₹41 to ₹43 per share. The company has set the face value at ₹10 per share. The IPO issue type is a fresh issue of ₹12 Cr. and an Offer for Sale of ₹- Cr. The listing is at BSE SME. Further, the minimum lot size is 1 of 3,000 shares each. The Goldline Pharmaceutical registrar is Bigshare Services Pvt.Ltd. This company provides marketing and distribution of generic pharmaceutical products.
Day-wise GMP Trend
| GMP Date | IPO Price | GMP | Estimated Listing Price | Expected Gain | Status | Last Updated |
|---|---|---|---|---|---|---|
| 18-Jun-2026 | ₹43 | ₹15 | 58 (34.88%) | 34.88% | Positive | 18-Jun-2026 15:12 |
| 18-May-2026 | ₹43 | ₹17 | 18-May-2026 16:32 |
Disclaimer: The grey market premium is only an unofficial news update. We do not trade in the grey market or recommend anyone to deal in it. Readers must consult a professional financial advisor, and any choice you make based on this information is at your own risk.
Day-wise Subscription Details
| Day | QIB | NII | Small NII | Big NII | Retail | Total |
|---|---|---|---|---|---|---|
| Day 1 | 1.31x | 24.46x | 28.68x | 22.35x | 34.07x | 22.35x |
| Day 2 | 1.31x | 146.12x | 120.85x | 158.76x | 139.51x | 100.14x |
| Day 3 | 180.22x | 1,661.23x | 993.42x | 1,995.14x | 875.29x | 837.68x |
| Day 4 | 180.22x | 1,662.04x | 995.84x | 1,995.14x | 881.15x | 840.74x |
No comments yet. Be the first to share your thoughts!